Cogent Biosciences Ownership | Who Owns Cogent Biosciences?


OverviewForecastRevenueFinancialsChart

Cogent Biosciences Ownership Summary


Cogent Biosciences is owned by 118.38% institutional investors, 0.04% insiders. Fmr is the largest institutional shareholder, holding 15.04% of COGT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.91% of its assets in Cogent Biosciences shares.

COGT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCogent Biosciences118.38%0.04%-18.42%
SectorHealthcare Stocks 479.67%11.03%-390.70%
IndustryBiotech Stocks 295.80%10.97%-206.77%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.57M15.04%$129.24M
Blackrock funding, inc. /de8.63M7.54%$61.94M
Kynam capital management, lp8.49M7.42%$60.98M
Blackrock7.29M7.34%$61.44M
Commodore capital lp6.88M6.25%$53.68M
Tcg crossover management6.96M6.08%$50.00M
Vanguard group6.13M5.57%$47.84M
Fairmount funds management6.23M5.44%$44.70M
Paradigm biocapital advisors lp4.92M4.46%$38.36M
Point72 asset management4.91M4.29%$35.27M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Superstring capital management lp962.95K8.19%$6.91M
Saturn v capital management2.30M6.69%$16.50M
Kynam capital management, lp8.49M6.56%$60.98M
Fairmount funds management6.23M5.79%$44.70M
Tcg crossover management6.96M5.71%$50.00M
Commodore capital lp6.88M3.93%$53.68M
Octagon capital advisors lp2.76M3.55%$21.55M
New leaf venture partners250.76K3.40%$1.80M
Vr adviser4.76M2.56%$34.14M
Exome asset management533.65K2.42%$3.83M

Top Buyers

HolderShares% AssetsChange
Fmr16.57M0.01%8.25M
Octagon capital advisors lp2.76M3.55%1.46M
Emerald advisers1.45M0.38%1.45M
Ikarian capital1.04M1.43%1.04M
Emerald mutual fund advisers trust895.41K0.39%895.41K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp---4.30M
Logos global management lp---2.00M
Redmile group1.45M1.11%-1.77M
Millennium management56.51K0.00%-1.56M
Franklin resources---1.33M

New Positions

HolderShares% AssetsChangeValue
Emerald advisers1.45M0.38%1.45M$10.38M
Ikarian capital1.04M1.43%1.04M$7.44M
Emerald mutual fund advisers trust895.41K0.39%895.41K$6.43M
Siren854.38K0.32%854.38K$6.13M
Rock springs capital management lp800.20K0.36%800.20K$5.75M

Sold Out

HolderChange
Clear point advisors-1.00
National bank of canada /fi/-1.00
Ifp advisors-8.00
Nelson, van denburg & campbell wealth management group-16.00
Larson financial group-16.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251915.52%135,507,9806.74%1180.94%1048.33%40-16.67%
Mar 31, 20251841.10%133,476,5659.67%1170.97%98-482.13%
Dec 31, 20241799.15%120,758,047-0.89%1090.90%9612.94%484.35%
Sep 30, 20241616.62%121,811,5570.36%1100.74%846.33%46-4.17%
Jun 30, 2024151-3.21%121,368,54811.09%1220.92%79-20.20%4837.14%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.06M2.91%592.96K
Vanguard US Total Market Shares ETF3.09M2.71%-
Fidelity Select Health Care3.14M2.25%875.82K
Fidelity Small Cap Growth2.57M1.85%-6.28K
iShares Russell 2000 ETF2.52M1.80%-47.77K
FIAM Small Cap Core Composite1.87M1.69%225.12K
Fidelity Advisor Biotechnology I2.00M1.43%665.41K
FIAM Small Cap Core CIT Cl B1.83M1.31%-15.60K
Fidelity Advisor Health Care I1.80M1.29%429.44K
Vanguard Institutional Extnd Mkt Idx Tr1.38M0.99%-278.29K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 10, 2025Fairmount Funds Management LLC-Buy$25.00M
Jan 14, 2025Pinnow Cole Chief Commercial OfficerBuy$332.41K
Jun 09, 2023Fairmount Funds Management LLC-Buy$9.60M
Jun 16, 2022Fairmount Funds Management LLC Buy$9.90M
Apr 26, 2021Green John L. Chief Financial OfficerSell$157.82K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q11-
2024 Q4--
2024 Q3--

COGT Ownership FAQ


Who Owns Cogent Biosciences?

Cogent Biosciences shareholders are primarily institutional investors at 118.38%, followed by 0.04% insiders and -18.42% retail investors. The average institutional ownership in Cogent Biosciences's industry, Biotech Stocks , is 295.80%, which Cogent Biosciences falls below.

Who owns the most shares of Cogent Biosciences?

Cogent Biosciences’s largest shareholders are Fmr (16.57M shares, 15.04%), Blackrock funding, inc. /de (8.63M shares, 7.54%), and Kynam capital management, lp (8.49M shares, 7.42%). Together, they hold 30.00% of Cogent Biosciences’s total shares outstanding.

Does Blackrock own Cogent Biosciences?

Yes, BlackRock owns 7.34% of Cogent Biosciences, totaling 7.29M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 61.44M$. In the last quarter, BlackRock increased its holdings by 598.76K shares, a 8.95% change.

Who is Cogent Biosciences’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Cogent Biosciences’s biggest shareholder by percentage of total assets invested, with 8.19% of its assets in 962.95K Cogent Biosciences shares, valued at 6.91M$.

Who is the top mutual fund holder of Cogent Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cogent Biosciences shares, with 2.91% of its total shares outstanding invested in 4.06M Cogent Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools